5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT06961955
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Breast Cancer
  • Ductal Breast Carcinoma in Situ
  • Invasive Carcinoma of Breast

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Radiation Therapy — RADIATION
    Undergo hypofractionated radiation therapy

Study Details

The goal of this study is to evaluate 5 days vs. 9 days of whole breast radiation.

Key Dates

Start date
May 21, 2025
Status verified
Dec 2025
Primary completion
May 31, 2030
Completion
May 31, 2033

Study Design

Enrollment
144 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: 5 fractions of radiotherapy (Arm 1)
  • Active Comparator: 9 fractions of radio therapy (Arm 2)

Primary Outcome Measure

24-month Mean breast overall satisfaction Breast - Q scores with 5 fractions of radiation is non-inferior in patient reported outcomes. [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Huntsman Cancer Institute/University of UtahSalt Lake CityUtah84112
Rachel Kingford
[email protected]
801-585-0115
David Samuel
[email protected]
801-587-4713
Matthew Poppe, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Salt Lake City, UT

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
Huntsman Cancer Institute/University of Utah· Salt Lake City, UT

Related Studies